| Product Name | MF | CAS | Details |
|---|
| 2,2,2-Trichloro-1-(4-iodo-1H-pyrrol-2-yl)ethanone | C6H3Cl3INO | 72652-33-6 | Details |
| 2-[(4-Amino-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl]acetic acid | C10H10N4O2S | 114402-22-1 | Details |
| 4-Bromo-5-methyl-2,3-dihydro-1H-isoindole | C9H10BrN | 1427361-78-1 | Details |
| 16-Methyl-16-dehydropregnenolone | C22H32O2 | 1808-63-5 | Details |
| RFESD Blocking Peptide | Details |
| Conarachin protein | Details |
| S-(2-Hydroxy-5-nitrobenzoyl)-6-thioguanosine | C17H18N6O7S | 41094-07-9 | Details |
| 5-(2-Phenylpropan-2-yl)-1,3,4-thiadiazol-2-amine | C11H13N3S | 1032463-93-6 | Details |
| 1-(2-Methylpropyl)-1H-pyrazole-5-carboxylic acid | C8H12N2O2 | 1006493-85-1 | Details |
| Ac-Phe-Thiaphe-OH | C19H20N2O4S | 108906-59-8 | Details |
| 1H-Indole-6-carbohydrazide | C9H9N3O | 851211-74-0 | Details |
| anti-Mouse IgM Antibody (Rabbit) - Affinity Purified | Details |
| 3-(Benzyloxy)-2-hydroxybenzaldehyde | C14H12O3 | 86734-59-0 | Details |
| 4-(Azidomethyl)-2-ethyl-1,3-thiazole | C6H8N4S | 1250225-58-1 | Details |
| Ethyl glycolate | C4H8O3 | 623-50-7 | Details |
| 2-(3,4-Dimethoxy-phenyl)-2-oxo-ethyl-ammonium chloride | C10H14ClNO3 | 61416-34-0 | Details |
| Fmoc-Homoarg (Z)2-OH | C38H38N4O8 | 1926163-01-0 | Details |
| Bis(6-chloro-3-indoxyl)pyrophosphoric acid, disodium salt | 937783-80-7 | Details |
| 1,4-Dibromo-2,5-difluorobenzene | C6H2Br2F2 | 327-51-5 | Details |
| Gpr34 receptor antagonist 2 | C31H26ClNO4 | 907952-06-1 | Details |
| H-Cys(Me)-OH | C4H9NO2S | 1187-84-4 | Details |
| H-QTALVELLK-OH | Details |
| ethyl 6-chloro-4-oxo-1,4-dihydroquinoline-2-carboxylate | C11H8ClNO3 | 7545-52-0 | Details |
| 4-[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)sulfamoyl]benzoic acid | C18H17N3O5S | 31816-70-3 | Details |
| 4-Cyano-3-methylphenylboronic acid pinacol ester | C14H18BNO2 | 775351-54-7 | Details |
| (3S)-3-(tert-Butoxy)piperidine hydrochloride | C9H19NO.ClH | 2243501-53-1 | Details |
| 6-Chloro-3-(2,2,2-trifluoro-1,1-dihydroxyethyl)-4H-chromen-4-one | C11H6ClF3O4 | 1211251-78-3 | Details |
| 4-(2-Iodophenyl)-1,3-oxazolidin-2-one | C9H8INO2 | 1823994-33-7 | Details |
| 1-Phenyl-1H-pyrrole-3-carbaldehyde | C11H9NO | 120777-22-2 | Details |
| (10E,12E)-10,12-Hexadecadienol | C16H30O | 765-19-5 | Details |
| 2-Methyl-6-(tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline | C16H20BNO2 | 1022090-86-3 | Details |
| 2-(5-Chlorothiophen-2-yl)imidazo[2,1-a]phthalazin-6-amine | C14H9ClN4S | 565168-88-9 | Details |
| 3-((4-(4,5-Dichloroimidazolyl)phenyl)amino)-5,5-dimethylcyclohex-2-en-1-one | C17H17Cl2N3O | 946386-31-8 | Details |
| O-tert-Butyl-L-serine | C7H15NO3 | 18822-58-7 | Details |
| Gancaonin G | C21H20O5 | 126716-34-5 | Details |
| SIV mac251 gp120 antibody (biotin) | Details |
| 1,3-O-Benzylidene-4-O-trityl-D-threitol | C11ClF15 | 1018330-39-6 | Details |
| Rovelizumab | 339086-79-2 | Details |
| 2-{[5-(2-Bromophenyl)-4-[3-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid | C17H11BrF3N3O2S | 743439-42-1 | Details |
| Sodium L-glutamate | C5H10NNaO4 | 142-47-2 | Details |
| 4-(Isopentyloxy)benzenecarboxylic acid | C12H16O3 | 2910-85-2 | Details |
| 1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-D-galactopyranose HCl | C14H22ClNO9 | 1355005-40-1 | Details |
| PUB75 antibody | Details |
| 3-(2-(Benzyloxy)ethoxy)propan-1-ol | C12H18O3 | 131326-24-4 | Details |
| 2-(5-Nitro-1H-pyrazol-1-yl)ethan-1-ol | C5H7N3O3 | 1026867-48-0 | Details |
| (1S)-7-Fluoro-1,2,3,4-tetrahydronaphthalen-1-ol | C10H11FO | 1083302-30-0 | Details |
| rac-(3R,4R)-3-Fluoro-4-phenylpyrrolidine hydrochloride | C10H13ClFN | 2227705-75-9 | Details |
| H-CVELERQLRKENEKQKNEL-OH | Details |
| ZNF346 antibody | Details |
| N1-(2-chloro-6-fluoro-3-nitrophenyl)acetamide | C8H6ClFN2O3 | 218796-15-7 | Details |
| N-[(Pyridin-3-yl)methyl]-2H-1,3-benzodioxol-5-amine | C13H12N2O2 | 791601-06-4 | Details |
| 1,2-Bis(2-(4,5-dihydro-1H-imidazol-2-yl)propan-2-yl)diazene dihydrochloride | C12H23ClN6 | 27776-21-2 | Details |
| 3-Chloro-4-(1,3-thiazol-2-yloxy)aniline | C9H7ClN2OS | 871021-06-6 | Details |
| ORC1L antibody | Details |
| 7-methyl-3-(4-methylphenyl)-6,7,8-trihydrocinnolin-5-one | C16H16N2O | 1024581-97-2 | Details |
| 1-N-(1-Methanesulfonylpiperidin-4-yl)-4-methylbenzene-1,3-diamine | C13H21N3O2S | 1409216-81-4 | Details |
| 2,3-Dichloro-N,N-dimethylquinoxaline-6-sulfonamide | C10H9Cl2N3O2S | 2347-47-9 | Details |
| 4-(5-Methyl-furan-2-yl)-phenylamine | C11H11NO | 60456-79-3 | Details |
| 2-Methyl-1-phenyl-1H-imidazole-5-carboxylic acid hydrochloride | C11H11ClN2O2 | 1354950-55-2 | Details |
| 1-Ethyl-3-(trifluoromethyl)-1H-pyrazole-5-carbaldehyde | C7H7F3N2O | 1443279-59-1 | Details |
| N-(1-Acetyl-2,3-dihydro-1H-indol-5-yl)-2-chloroacetamide | C12H13ClN2O2 | 893722-06-0 | Details |
| 6-Fluoro-3,4-dihydro-2H-1-benzopyran-3-amine hydrochloride | C9H11ClFNO | 1803587-71-4 | Details |
| 2-[(Dimethyl-1H-1,2,4-triazol-1-yl)methyl]morpholine hydrochloride | C9H17ClN4O | 1354952-90-1 | Details |
| 10,12-Heptadecadiynoic Acid | C17H26O2 | 28393-06-8 | Details |
| 4-Iododiphenylmethane | C13H11I | 35444-94-1 | Details |
| Rat TrkA ELISA Kit | Details |
| Methyl 2-ethynylisonicotinate | C9H7NO2 | 1256810-92-0 | Details |
| H-VAGQDGSVVQFK-OH | Details |
| aza(3-(2,4-dichlorophenyl)-7-methyl(6,7,8-trihydrocinnolin-5-ylidene))ethoxymethane | C17H17Cl2N3O | 1024826-51-4 | Details |
| Coclaurine | C17H19NO3 | 486-39-5 | Details |
| 3-Chloro-5-{[(4-methylphenyl)methyl]sulfanyl}-1,2,4-thiadiazole | C10H9ClN2S2 | 1803600-55-6 | Details |
| 2-(1,2,3,4-Tetrahydroquinolin-4-yl)acetic acid hydrochloride | 2174002-63-0 | Details |
| [2-(4-Methoxyphenyl)-1-methylpiperidin-3-yl]methanol | C14H21NO2 | 75810-59-2 | Details |
| SIVmac239 - 42 | C73H111N17O22 | Details |
| LIN7B protein (His tag) | Details |
| N-Cis-octadec-9Z-enoyl-L-homoserine lactone | C22H39NO3 | 1400974-23-3 | Details |
| Defensin (human) HNP-2 | C147H223N43O37S6 | Details |
| 2-(3-Aminopyrrolidin-1-yl)-6-methyl-3,4-dihydropyrimidin-4-one dihydrochloride | 2094621-07-3 | Details |
| 6-Methoxy-2,3,4,9-tetrahydro-1H-carbazol-1-one | C13H13NO2 | 3449-49-8 | Details |
| MMP Inhibitor II | C21H27N3O8S2 | 203915-59-7 | Details |
| H-INITRFQTL-OH | Details |
| Mitorubrinol | C21H18O8 | 3215-47-2 | Details |
| 6-Methyl-5,6,7,8-tetrahydronaphthalen-2-amine | C11H15N | 1780674-52-3 | Details |
| 5-Bromo-1-(2,2-difluorocyclopropyl)-1H-pyrazole | C6H5BrF2N2 | 2225144-53-4 | Details |
| 1,2-Dimethyl 3-amino-4-hydroxybenzene-1,2-dicarboxylate | C10H11NO5 | 142671-52-1 | Details |
| CLK2 antibody | Details |
| N-(2-Methoxyethyl)-6-methylpiperidine-3-carboxamide | C10H20N2O2 | 1016857-64-9 | Details |
| Methyl 2-(aminomethyl)butanoate hydrochloride | C6H14ClNO2 | 448948-17-2 | Details |
| N-Methyl-4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}aniline | C13H11F3N2O | 1183362-22-2 | Details |
| tert-Butyl 3-methanesulfonyl-2-oxo-1,2,5,6,7,8-hexahydro-1,6-naphthyridine-6-carboxylate | C14H20N2O5S | 1333763-64-6 | Details |
| Huanbifucaotong | C20H19ClF3N3O3 | 1855929-45-1 | Details |
| CMVpp65 - 84 (IRETVELRQYDPVAA) | Details |
| GP120 - W61D - 26 | C79H120N20O28S | Details |
| Survivin antibody (Thr34) | Details |
| 2-(tert-butoxy)pyridine-3-sulfinate lithium | C9H14LiNO3S | 2174001-63-7 | Details |
| 1-Chlorocyclobutane-1-sulfonamide | C4H8ClNO2S | 2137831-88-8 | Details |
| N1,N1,N4-Trimethylcyclohexane-1,4-diamine | C9H20N2 | 1048918-81-5 | Details |
| Recombinant Human FGF-21 | Details |
| H-QLYENKPRRPYIL-OH | Details |
| 3-Methyl-6,7-dihydro-1,2-benzoxazol-4-ol | C8H9NO2 | 383377-52-4 | Details |
| Product Total： Product Page： | ||||
| 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 | ||||